Rama Vision Limited (RAMAVISION.BO)
INR 94.98
(5.18%)
INR 94.98
(5.18%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 895.7 Million INR | 9.42% |
| 2022 | 818.56 Million INR | 32.57% |
| 2021 | 617.44 Million INR | 12.18% |
| 2020 | 550.41 Million INR | 27.06% |
| 2019 | 433.17 Million INR | 22.56% |
| 2018 | 353.44 Million INR | 20.0% |
| 2017 | 294.54 Million INR | -10.19% |
| 2016 | 327.95 Million INR | 8.69% |
| 2015 | 301.72 Million INR | -27.67% |
| 2014 | 417.13 Million INR | 25.23% |
| 2013 | 333.09 Million INR | 12.86% |
| 2012 | 295.14 Million INR | 37.27% |
| 2011 | 215.01 Million INR | 23.42% |
| 2010 | 174.21 Million INR | 42.66% |
| 2009 | 122.11 Million INR | 23.68% |
| 2008 | 98.73 Million INR | 38.86% |
| 2007 | 71.1 Million INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 268.28 Million INR | 16.86% |
| 2023 Q4 | 229.58 Million INR | -6.04% |
| 2023 Q3 | 244.34 Million INR | 11.26% |
| 2023 FY | 895.7 Million INR | 9.42% |
| 2023 Q2 | 219.6 Million INR | 8.62% |
| 2023 Q1 | 202.17 Million INR | 3.7% |
| 2022 Q2 | 207.29 Million INR | 6.57% |
| 2022 FY | 818.56 Million INR | 32.57% |
| 2022 Q4 | 194.95 Million INR | -12.1% |
| 2022 Q3 | 221.79 Million INR | 6.99% |
| 2022 Q1 | 194.52 Million INR | 12.59% |
| 2021 FY | 617.44 Million INR | 12.18% |
| 2021 Q4 | 172.77 Million INR | 1.46% |
| 2021 Q1 | 123.12 Million INR | -12.76% |
| 2021 Q2 | 151.26 Million INR | 22.85% |
| 2021 Q3 | 170.28 Million INR | 12.58% |
| 2020 Q1 | 112.91 Million INR | 16.19% |
| 2020 FY | 550.41 Million INR | 27.06% |
| 2020 Q4 | 141.13 Million INR | -4.24% |
| 2020 Q3 | 147.38 Million INR | -1.07% |
| 2020 Q2 | 148.97 Million INR | 31.94% |
| 2019 Q1 | 111.44 Million INR | 23.39% |
| 2019 Q4 | 97.18 Million INR | -14.89% |
| 2019 FY | 433.17 Million INR | 22.56% |
| 2019 Q2 | 110.35 Million INR | -0.97% |
| 2019 Q3 | 114.19 Million INR | 3.48% |
| 2018 Q2 | 85.27 Million INR | 0.7% |
| 2018 Q1 | 84.67 Million INR | 17.82% |
| 2018 Q4 | 90.31 Million INR | -3.07% |
| 2018 FY | 353.44 Million INR | 20.0% |
| 2018 Q3 | 93.17 Million INR | 9.28% |
| 2017 Q4 | 71.86 Million INR | -6.85% |
| 2017 Q2 | 81.31 Million INR | 26.63% |
| 2017 Q1 | 64.21 Million INR | -25.24% |
| 2017 FY | 294.54 Million INR | -10.19% |
| 2017 Q3 | 77.15 Million INR | -5.12% |
| 2016 Q1 | 75.37 Million INR | 8.64% |
| 2016 FY | 327.95 Million INR | 8.69% |
| 2016 Q4 | 85.89 Million INR | -0.01% |
| 2016 Q3 | 85.9 Million INR | 6.34% |
| 2016 Q2 | 80.78 Million INR | 7.17% |
| 2015 FY | 301.72 Million INR | -27.67% |
| 2015 Q4 | 69.38 Million INR | -11.29% |
| 2015 Q3 | 78.21 Million INR | 4.3% |
| 2015 Q2 | 74.99 Million INR | -5.24% |
| 2015 Q1 | 79.14 Million INR | -33.17% |
| 2014 Q2 | 101.31 Million INR | 3.56% |
| 2014 FY | 417.13 Million INR | 25.23% |
| 2014 Q4 | 118.42 Million INR | 18.95% |
| 2014 Q3 | 99.55 Million INR | -1.74% |
| 2014 Q1 | 97.83 Million INR | 16.56% |
| 2013 FY | 333.09 Million INR | 12.86% |
| 2013 Q1 | 75.71 Million INR | 3.58% |
| 2013 Q2 | 85.25 Million INR | 12.61% |
| 2013 Q3 | 77.7 Million INR | -8.86% |
| 2013 Q4 | 83.93 Million INR | 8.01% |
| 2012 Q3 | 77.7 Million INR | 7.68% |
| 2012 Q4 | 73.09 Million INR | -5.93% |
| 2012 FY | 295.14 Million INR | 37.27% |
| 2012 Q1 | 72.18 Million INR | 13.28% |
| 2012 Q2 | 72.16 Million INR | -0.04% |
| 2011 Q2 | 48.52 Million INR | 8.08% |
| 2011 Q1 | 44.9 Million INR | 0.0% |
| 2011 FY | 215.01 Million INR | 23.42% |
| 2011 Q4 | 63.72 Million INR | 10.12% |
| 2011 Q3 | 57.86 Million INR | 19.24% |
| 2010 FY | 174.21 Million INR | 42.66% |
| 2009 FY | 122.11 Million INR | 23.68% |
| 2008 Q4 | 27.47 Million INR | 0.0% |
| 2008 FY | 98.73 Million INR | 38.86% |
| 2007 FY | 71.1 Million INR | 0.0% |
| 2007 Q4 | 19.26 Million INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Chandra Bhagat Pharma Limited | 2.22 Billion INR | 59.744% |
| Checkpoint Trends Limited | 11.3 Million INR | -7820.04% |
| Everest Organics Limited | 1.97 Billion INR | 54.588% |
| GUJARAT INJECT (KERALA) LTD. | 57.88 Million INR | -1447.428% |
| NATURO INDIABULL LIMITED | 418.93 Million INR | -113.807% |
| NEXUS SURGICAL AND MEDICARE LI | 34.74 Million INR | -2478.138% |
| Rajnish Wellness Limited | 766.84 Million INR | -16.804% |
| Vivo Bio Tech Limited | 454.51 Million INR | -97.07% |